GO:0001616 growth hormone secretagogue receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001616 (growth hormone secretagogue receptor activity) is a molecular function defined as combining with ghrelin to initiate a change in cell activity.
• The receptor is best known as GHSR, a G protein-coupled receptor whose canonical ligand is the orexigenic hormone ghrelin.
• GHSR signaling is unusual because it shows ligand-independent (constitutive) activity that can shape neuronal excitability and calcium channel function.
• Beyond appetite control, GHSR activity influences growth hormone release, macrophage programming, meta-inflammation and nutrient sensing.
• GHSR is a tractable drug target, and its activity can be probed with agonists, inverse agonists and genetic models such as knockout mice.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models allow causal testing of GHSR variants and signaling states.
Description
GO:0001616, growth hormone secretagogue receptor activity, is a molecular function in which a receptor combines with the hormone ghrelin to initiate a change in cell activity. This activity is most commonly associated with the growth hormone secretagogue receptor, GHSR, a G protein-coupled receptor that was originally identified through its ability to stimulate growth hormone release. The receptor is now recognized as a central node linking nutrient status, appetite and neuroendocrine output. For researchers, GO:0001616 matters because it provides a precise functional annotation for experiments that measure ghrelin-dependent signaling, receptor constitutive activity and downstream cellular responses. The term is also clinically relevant: GHSR activity has been implicated in metabolic disease, inflammation and growth and developmental biology. Because the receptor can signal in both ligand-dependent and ligand-independent ways, careful genetic and pharmacological dissection is required to assign function accurately.
growth hormone secretagogue receptor activity At A Glance
| GO ID | GO:0001616 |
|---|---|
| GO term | growth hormone secretagogue receptor activity |
| Ontology | molecular_function |
| Synonym | ghrelin receptor activity |
| Definition | Combining with ghrelin to initiate a change in cell activity |
| Major function | Ghrelin-dependent receptor signaling that alters cell activity |
| Representative receptor | GHSR (growth hormone secretagogue receptor) |
| Canonical ligand | Ghrelin |
| Signaling class | G protein-coupled receptor activity |
| Related biology | Appetite, growth hormone release, nutrient sensing, inflammation |
What Is GO:0001616?
In plain terms, GO:0001616 describes the job of a receptor when it binds ghrelin and triggers a change inside the cell. The QuickGO definition states that this activity is the combining with ghrelin to initiate a change in cell activity. It is a molecular_function term, and its synonym is ghrelin receptor activity. This function is not simply the presence of the receptor protein; it is the receptor's ability to engage ghrelin and convert that binding event into downstream signaling.
Why Is growth hormone secretagogue receptor activity Important in Cell Biology?
GO:0001616 is important because it captures a specific, experimentally testable receptor function that connects an endocrine ligand to cellular behavior. GHSR activity is a key control point for appetite and energy balance, and it also contributes to growth hormone secretion and broader neuroendocrine regulation. Recent work has extended its relevance to immune-metabolic crosstalk, showing that nutrient-sensing GHSR in macrophages can shape meta-inflammation. The receptor's constitutive activity further complicates interpretation, because signaling can occur even without ghrelin and can affect neuronal calcium channels and inhibitory neurotransmission. These features make GO:0001616 a valuable annotation for genetic, pharmacological and CRISPR-based studies that seek to separate ligand-dependent from ligand-independent effects.
• Defines a druggable GPCR function that can be activated or blocked to alter appetite and metabolism.
• Links ghrelin binding to growth hormone release and neuroendocrine control.
• Supports nutrient-sensing and immune-metabolic research through macrophage GHSR signaling.
• Provides a framework for studying constitutive, ligand-independent receptor activity.
• Relevant to obesity and feeding behavior, as shown by genetic and pharmacological studies.
• Contributes to growth and developmental biology through ghrelin-GHSR signaling.
• Enables precise functional annotation in knockout and knock-in experiments.
• Helps interpret off-target or paradoxical drug effects, such as liraglutide responses in GHSR-null mice.
• Connects receptor activity to calcium channel regulation and neuronal excitability.
• Offers a model system for studying GPCR constitutive activity and inverse agonism.
Molecular Mechanism of growth hormone secretagogue receptor activity
Ghrelin binding and receptor activation
In simple terms: Ghrelin acts like a key that fits the GHSR lock and switches the receptor on.
The defining event of GO:0001616 is the combination of ghrelin with the growth hormone secretagogue receptor, which initiates a change in cell activity. GHSR is a G protein-coupled receptor, and ghrelin is its canonical endogenous ligand. This ligand-receptor interaction is the molecular basis for the term's synonym, ghrelin receptor activity. The receptor family and its ligands have been characterized as part of the growth hormone secretagogue system.
Constitutive activity and ligand-independent signaling
In simple terms: The receptor can sometimes signal even without ghrelin, like a switch that is partly on by itself.
GHSR exhibits constitutive activity, meaning it can signal in the absence of ghrelin. In hippocampal neurons, this constitutive activity impairs voltage-gated calcium channel-dependent inhibitory neurotransmission. This property distinguishes GHSR from simple ligand-gated switches and requires careful experimental design to separate basal from ghrelin-evoked signaling. The ups and downs of GHSR signaling have been reviewed in detail, highlighting the importance of context in interpreting receptor activity.
Downstream cellular responses
In simple terms: Once switched on, the receptor changes how the cell behaves, including its electrical activity and gene programs.
Activation of GHSR leads to changes in cell activity that can include altered neuronal excitability and calcium channel function. In immune cells, nutrient-sensing GHSR contributes to macrophage programming and meta-inflammation, linking receptor activity to inflammatory gene expression. The receptor also participates in growth hormone release and broader growth and developmental processes. These downstream effects are context-dependent and are best studied with cell-type-specific models.
Regulation by ligands and pharmacological tools
In simple terms: Drugs and natural hormones can turn the receptor up or down, which helps researchers test what it does.
GHSR activity can be modulated by agonists, antagonists and inverse agonists, making it a tractable pharmacological target. Liraglutide, a GLP-1 receptor agonist, induces enhanced suppression of food intake in mice lacking GHSR, indicating crosstalk between GHSR and other metabolic pathways. Such pharmacological dissections are essential for assigning causality to GO:0001616 in vivo. The receptor's role in appetite and energy balance has been reviewed in the context of drug development.
Receptor structure and signaling class
In simple terms: GHSR belongs to a large family of receptors that snake through the cell membrane and use G proteins to send signals.
GHSR is a G protein-coupled receptor, a class of membrane proteins that transduce extracellular signals into intracellular responses. The growth hormone secretagogue receptor family and its ligands have been described, providing a structural and evolutionary context for GO:0001616. This receptor architecture underlies its ability to combine with ghrelin and initiate changes in cell activity. Understanding the structural basis of GHSR function supports rational design of modulators.
Key Genes Involved in GO:0001616 growth hormone secretagogue receptor activity
The following genes and proteins are central to growth hormone secretagogue receptor activity and its downstream biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GHSR | Encodes the growth hormone secretagogue receptor, the receptor that binds ghrelin | Primary gene for GO:0001616; target of knockout, knock-in and pharmacological studies |
| GHRL | Encodes ghrelin, the endogenous ligand that combines with GHSR | Ligand for receptor activation assays and feeding studies |
| GNAQ | G protein alpha subunit that can couple to GHSR | Downstream signaling mediator in GPCR pathways |
| GNA11 | G protein alpha subunit family member | Potential coupling partner in GHSR signaling |
| GNAI1 | Inhibitory G protein alpha subunit | May contribute to GHSR-mediated signaling |
| GNAI2 | Inhibitory G protein alpha subunit | May contribute to GHSR-mediated signaling |
| GNAI3 | Inhibitory G protein alpha subunit | May contribute to GHSR-mediated signaling |
| GNAS | Stimulatory G protein alpha subunit | Potential coupling partner for GHSR |
| CACNA1B | Voltage-gated calcium channel subunit | Implicated in GHSR constitutive activity effects on neurotransmission |
| CACNA1A | Voltage-gated calcium channel subunit | Related to calcium channel-dependent neuronal functions |
| GHRH | Growth hormone-releasing hormone | Neuroendocrine context for growth hormone secretagogue activity |
| SST | Somatostatin | Counter-regulatory hormone in growth hormone axis |
| GHRHR | Growth hormone-releasing hormone receptor | Related GPCR in the growth hormone secretagogue family |
| NPY | Neuropeptide Y | Downstream feeding circuit component |
| AGRP | Agouti-related peptide | Hypothalamic feeding circuit component |
| POMC | Pro-opiomelanocortin | Hypothalamic feeding circuit component |
| LEPR | Leptin receptor | Metabolic signaling context for GHSR |
| IL6 | Interleukin 6 | Inflammatory mediator linked to meta-inflammation |
| TNF | Tumor necrosis factor | Inflammatory mediator linked to meta-inflammation |
How Is growth hormone secretagogue receptor activity Regulated?
GHSR activity is regulated at multiple levels, including ligand availability, receptor constitutive activity and crosstalk with other metabolic receptors. Ghrelin is the canonical ligand, but the receptor can also signal without it, and this constitutive activity is a key regulatory feature. Pharmacological agents such as liraglutide can modulate feeding behavior in a GHSR-dependent manner, indicating that GHSR activity is integrated with other hormonal pathways. Nutrient-sensing GHSR in macrophages further shows that receptor activity is tuned by the metabolic environment. These layers of regulation mean that GO:0001616 should be interpreted in the context of cell type, ligand status and genetic background.
growth hormone secretagogue receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GHSR | Obesity and feeding disorders | GHSR knockout mouse, hypothalamic cell lines |
| GHSR | Meta-inflammation and macrophage programming | Macrophage-specific GHSR knockout or overexpression |
| GHSR | Growth and developmental disorders | Knock-in or point-mutation models in growth axis |
| GHSR | Neurological excitability disorders | Hippocampal neuron knockout or constitutive-active knock-in |
| GHRL | Appetite and metabolic regulation | Ghrelin knockout or receptor agonist studies |
Metabolic and feeding disorders
GHSR activity is centrally involved in appetite and energy balance, and its dysfunction has been linked to obesity and feeding disorders. Studies in mice lacking GHSR show altered responses to pharmacological agents such as liraglutide, highlighting the receptor's role in food intake regulation. The ghrelin-GHSR axis is therefore a major focus for metabolic disease research.
Inflammation and meta-inflammation
Nutrient-sensing GHSR in macrophages contributes to macrophage programming and meta-inflammation, connecting receptor activity to chronic inflammatory states associated with metabolic disease. This expands the disease relevance of GO:0001616 beyond the central nervous system to immune-metabolic crosstalk.
Growth and developmental disorders
Ghrelin and the growth hormone secretagogue receptor play roles in growth and development, and their dysfunction may contribute to growth-related pathologies. The receptor's ability to stimulate growth hormone release places it within the growth hormone axis. Research into GO:0001616 therefore informs developmental and endocrine disorders.
Neurological and psychiatric conditions
GHSR constitutive activity impairs voltage-gated calcium channel-dependent inhibitory neurotransmission in hippocampal neurons, suggesting a role in neuronal excitability and potentially in neurological conditions. The receptor's broad expression in the brain supports its relevance to neuropsychiatric research. However, causal links to specific neurological diseases require further study.
From growth hormone secretagogue receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GHSR mediate ghrelin-dependent feeding? | GHSR knockout mouse |
| Does constitutive GHSR activity alter neuronal calcium channels? | Point-mutation knock-in of constitutive-active GHSR |
| How does GHSR signaling affect macrophage inflammation? | Macrophage-specific GHSR knockout or overexpression |
| What is the effect of a disease-associated GHSR variant? | Knock-in of the variant in cell lines or mice |
| Where is GHSR expressed and trafficked? | Tagged knock-in with fluorescent or epitope tag |
| Can GHSR activity be modulated pharmacologically? | Overexpression in heterologous cells plus agonist treatment |
How to Study the growth hormone secretagogue receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding | Ghrelin-receptor interaction | Receptor affinity and ligand competition |
| cAMP assay | G protein-coupled signaling | Agonist and inverse agonist profiling |
| Calcium imaging | Intracellular calcium changes | Neuronal GHSR activity |
| Electrophysiology | Ion channel function and excitability | Constitutive GHSR effects on neurotransmission |
| RNA sequencing | Transcriptional changes | Macrophage programming and inflammation |
| Proteomics | Protein expression and modifications | Downstream signaling networks |
| Knockout mouse | Requirement for GHSR in vivo | Feeding and metabolic studies |
| Knock-in mouse | Effect of specific GHSR variants | Constitutive activity and disease variants |
Ligand binding and signaling assays
Receptor activity can be measured using radioligand binding, cAMP accumulation, calcium mobilization or reporter gene assays in cells expressing GHSR. These assays distinguish ghrelin-dependent activation from constitutive activity. Pharmacological profiling with agonists and inverse agonists helps define the functional state of the receptor.
Genetic knockout and knock-in models
Knockout mice and cell lines are used to test the requirement for GHSR in feeding, growth and inflammation. Knock-in of point mutations allows dissection of constitutive versus ligand-dependent signaling. These models are essential for causal inference in GO:0001616 research.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can identify downstream gene programs altered by GHSR activity in macrophages and neurons. Such profiling reveals context-specific effectors of receptor signaling. Integrating these datasets with GO:0001616 annotation helps interpret functional enrichment.
Imaging and electrophysiology
Calcium imaging and electrophysiology can measure the impact of GHSR activity on neuronal excitability and calcium channel function. These methods are particularly useful for studying constitutive activity in hippocampal neurons. They complement biochemical assays by providing real-time functional readouts.
How CRISPR Can Be Used to Study GO:0001616 growth hormone secretagogue receptor activity
Knockout
CRISPR knockout of GHSR can eliminate receptor activity to test its requirement in feeding, growth and inflammation. Knockout models are particularly valuable for distinguishing GHSR-dependent from GHSR-independent effects of pharmacological agents. Such models also help validate the specificity of GO:0001616 annotations.
Point Mutation
Point mutations can be introduced into GHSR to mimic constitutive-active or loss-of-function states, allowing precise dissection of ligand-dependent versus ligand-independent signaling. These models are useful for studying disease-associated variants and for testing inverse agonists. CRISPR point-mutation editing enables isogenic comparisons in relevant cell types.
Knock-in
Knock-in of tags or reporters at the GHSR locus allows visualization of receptor expression and trafficking in native contexts. Knock-in of human variants into mouse models can reveal species-specific differences in receptor activity. These approaches support functional annotation of GO:0001616 in vivo.
Overexpression
Overexpression of GHSR in heterologous cells or specific tissues can amplify signaling for biochemical and pharmacological assays. Overexpression models are useful for screening agonists and antagonists and for studying downstream pathways. However, results should be interpreted with caution because overexpression can alter receptor stoichiometry.
How EDITGENE Supports growth hormone secretagogue receptor activity Research
Researchers studying growth hormone secretagogue receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, metabolic regulation or inflammation. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for growth hormone secretagogue receptor activity research.
Frequently Asked Questions About growth hormone secretagogue receptor activity
What is growth hormone secretagogue receptor activity?
It is the molecular function defined by GO:0001616, in which a receptor combines with ghrelin to initiate a change in cell activity.
What gene encodes the growth hormone secretagogue receptor?
The GHSR gene encodes the growth hormone secretagogue receptor, a G protein-coupled receptor.
What is the ligand for GO:0001616?
The canonical ligand is ghrelin, which binds GHSR to activate signaling.
What diseases are linked to GHSR activity?
GHSR activity has been linked to obesity, feeding disorders, meta-inflammation and growth-related conditions.
Does GHSR have constitutive activity?
Yes, GHSR can signal without ghrelin, and this constitutive activity affects neuronal calcium channels and neurotransmission.
How can I study growth hormone secretagogue receptor activity in the lab?
Common methods include ligand binding assays, cAMP and calcium assays, electrophysiology, and CRISPR knockout or knock-in models.
What is the role of GHSR in macrophages?
Nutrient-sensing GHSR in macrophages contributes to macrophage programming and meta-inflammation.
Can CRISPR be used to model GHSR mutations?
Yes, CRISPR knockout, point mutation and knock-in approaches are widely used to study GHSR function and disease variants.
What is the difference between GHSR and ghrelin receptor?
They refer to the same activity; ghrelin receptor activity is a synonym for GO:0001616.
Why is GO:0001616 important for drug discovery?
Because GHSR is a druggable GPCR involved in appetite, metabolism and inflammation, making it a target for therapeutic modulation.
Conclusion
GO:0001616, growth hormone secretagogue receptor activity, defines a specific and biologically important receptor function that links ghrelin to changes in cell activity. Its relevance spans appetite control, growth hormone release, neuronal excitability and immune-metabolic crosstalk. Because GHSR can signal both with and without ligand, careful genetic and pharmacological models are essential for accurate functional annotation. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide powerful tools to dissect these mechanisms and to translate them into therapeutic insights.
References
- 1. Cornejo MP et al.. 2021. The ups and downs of growth hormone secretagogue receptor signaling.. FEBS J 288(24):7213-7229 PMID: 33460513
- 2. Kim DM et al.. 2024. Nutrient-sensing growth hormone secretagogue receptor in macrophage programming and meta-inflammation.. Mol Metab 79:101852 PMID: 38092245
- 3. Cassano DA et al.. 2025. Liraglutide induces enhanced suppression of food intake in mice lacking the growth hormone secretagogue receptor.. Mol Cell Endocrinol 608:112627 PMID: 40738311
- 4. Martínez Damonte V et al.. 2018. Growth hormone secretagogue receptor constitutive activity impairs voltage-gated calcium channel-dependent inhibitory neurotransmission in hippocampal neurons.. J Physiol 596(22):5415-5428 PMID: 30199095
- 5. Cruz CR et al.. 2008. The growth hormone secretagogue receptor.. Vitam Horm 77:47-88 PMID: 17983853
- 6. Smith RG et al.. 2001. Growth hormone secretagogue receptor family members and ligands.. Endocrine 14(1):9-14 PMID: 11322507
- 7. Laviano A et al.. 2012. The growth hormone secretagogue receptor (Ghs-R).. Curr Pharm Des 18(31):4749-54 PMID: 22632856
- 8. Chanoine JP et al.. 2009. Ghrelin and the growth hormone secretagogue receptor in growth and development.. Int J Obes (Lond) 33 Suppl 1:S48-52 PMID: 19363508
